Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator

Experimental Nephrology

Volumn 8, Issue 6, 2000, Pages 332-342

  Kunzelmann, Karl ^a   Nitschke, Roland ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CFTR; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Processing; Traffic

Indexed keywords

CHLORIDE CHANNEL; CHLORIDE ION; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CELLULAR DISTRIBUTION; CYSTIC FIBROSIS; DISEASE ASSOCIATION; ENDOCYTOSIS; EXOCYTOSIS; GENE MUTATION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW;

EID: 0033798175     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020687     Document Type: Review

References (158)

1. Kunzelmann K: The cystic fibrosis transmembrane conductance regulator and its function in epithelial transport. Rev Physiol Biochem Pharmacol 1999;137:1-70.
2. Pilewski JM, Frizzell RA: Role of CFTR in airway disease. Physiol Rev. 1999;79(suppl):215-255.
3. Kunzelmann K, Schreiber R: CFTR, a regulator of channels. J Membr Biol 1999;168:1-8.
4. Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB: CFTR is a conductance regulator as well as a chloride channel. Physiol Rev. 1999;79(suppl):145-166.
5. Riordan JR, Rommels JM, Kerem B-S, Alon N. Rozmahel R, Grzelezak Z, Zielenski J, Plavsic SLN, Chou J-L, Drumm ML, Iannuzzi CM, Collins FS, Tsui L-C: Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989;245: 1066-1072.
6. Lukacs GL, Abdalla M, Kartner N, Riordan JR, Grinstein S: Conformational maturation of CFTR but its mutant counterpart (deltaF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 1994;13:6076-6086.
7. Riordan JR: The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 1993;55:609-630.
8. Mathews CJ, Tabeharani JA, Chang XB, Jensen TJ, Riordan JR, Hanrahan JW: Dibasic protein kinase A sites regulate bursting rate and nucleotide sensitivity of the cystic fibrosis transmembrane conductance regulator chloride channel. J Physiol (Lond) 1998:508:365-377.
9. Chang X-B, Tabeharani JA, Hou Y-X, Jensen TJ, Kartner N, Alon N, Hanrahan JW, Riordan JR: Protein kinase A (PKA) still activates CFTR chloride channels after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem 1993;268:11304-11311.
10. Steagall WK, Kelley TJ, Marsick RJ, Drumm ML: Type II protein kinase A regulates CFTR in airway, pancreatic, and intestinal cells. Am J Physiol 1998;274:C819-C826.
11. Fuller CM, Benos DJ: CFTR! Am J Physiol 1992;263:C267-C286.
12. Chang X-B, Hou YX, Jensen TJ, Riordan JR: Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. J Biol Chem 1994; 269:18572-18575.
13. Akabas MH, Kaufmann C, Cook TA, Archdeacon P: Amino acid residues lining the chloride channel of cystic fibrosis transmembrane conductance regulator. J Biol Chem 1995;269: 14865-14868.
14. Ko YH, Delannoy M, Pedersen PL: Cystic fibrosis transmembrane conductance regulator: The first nucleotide binding fold targets the membrane with retention of its ATP binding function. Biochemistry 1997;36:5053-5064.
15. Arispe N, Rojas E, Hartman J, Sorscher EJ, Pollard HB: Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein. Proc Natl Acad Sci USA 1992;89:1539-1543.
16. Ko YH, Thomas PJ, Delannoy MR, Pedersen PL: The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J Biol Chem 1993;268:24330-24338.
17. Gruis DB, Price EM: The nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator are extracellularly accessible. Biochemistry 1997;36:7739-7745.
18. Annereau JP, Wulbrand U, Vankeerberghen A, Cuppens H, Bontems F, Tummler B, Cassiman JJ, Stoven V: A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. FEBS Lett 1997;407:303-308.
19. Bianchet MA, Ko YH, Amzel LM, Pedersen PL: Modeling of nucleotide binding domains of ABC transporter proteins based on a Fl-ATPase/recA topology: Structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR). J Bioenerg Biomembr 1997;29:503-524.
20. Hung LW, Wang IX, Nikaido K, Liu PQ, Ames GF, Kim SH: Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 1998;396:703-707.
21. - channels with altered pore properties. Nature 1993;362:160-164.
22. Welsh MJ, Smith AE: Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254.
23. Tsui L-C, Durie P: Genotype and phenotype in cystic fibrosis. Hosp Pract 1997;32:115-118, 123-129, 134.
24. Wilschanski MA, Zielenski J, Markiewicz D, Tsui L-C, Corey M, Levison H, Durie PR: Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr 1995;127:705-710.
25. Schultz BD, Singh AK, Devor DC, Bridges RJ: Pharmacology of CFTR chloride channel activity. Physiol Rev 1999;79(suppl):109-144.
26. Smith JJ, Travis SM, Greenberg EP, Welsh MJ: Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996;85:229-236.
27. Barasch J, Kiss B, Prince A, Saiman L, Gruenert DC, al-Awqati Q: Defective acidification of intracellular organelles in cystic fibrosis. Nature 1991;352:70-73.
28. Kuver R, Ramesh N, Lau S, Savard C, Lee SP, Osborne WR: Constitutive mucin secretion linked to CFTR expression. Biochem Biophys Res Commun 1994;203:1457-1462.
29. Schreiber R, Greger R, Kunzelmann K: Cystic fibrosis transmembrane conductance regulator activates water conductance in Xenopus oocytes. Pflügers Arch 1997;434:841-847.
30. Schreiber R, Nitschke R, Greger R, Kunzelmann K: CFTR activates AQP3 in airway epithelial cells. J Biol Chem 1998;274:11811-11816.
31. Zeng W, Lee MG, Yan M, Diaz J, Benjamin I, Marino CR, Kopito RR, Freedman S, Cotton C, Muallem S, Thomas P: Immuno and functional characterization of CFTR in submandibular and pancreatic acinar and duct cells. Am J Physiol 1997;273:C442-C455.
32. Crawford I, Maloney PC, Zeitlin PL, Guggino WB, Hyde SC. Turley H, Gatter KC, Harris A, Higgins CF: Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA 1991;88:9262-9266.
33. - conductance in both cell membranes of an absorptive epithelium. J Membr Biol 1992;130:49-62.
34. Reynaert I, Van Der Schueren B, Degeest G, Manin M, Cuppens H, Scholte B, Cassiman JJ: Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, deltaF508 and knock-out CFTR mice during postnatal life. Mol Reprod Dev 2000;55(2): 125-135.
35. Gadsby DC, Nagel G, Hwang T-C: The CFTR chloride channel of mammalian heart. Annu Rev Physiol 1995;57:387-416.
36. Morales MM, Carroll TP, Morita T, Schwiebert EM, Devuyst O, Wilson PD, Lopes AG, Stanton BA, Dietz HC, Cutting GR, Guggino WB: Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol 1996;270:F1038-F1048.
37. Mulberg AE, Resta LP, Wiedner EB, Altschuler SM, Jefferson DM, Broussard DL: Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain. J Clin Invest 1995;96: 646-652.
38. Stanton BA: Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function. Wien Klin Wochenschr 1997;109:457-464.
39. McDonald TV, Nghiem PT, Gardner P, Martens CL: Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current. J Biol Chem 1992; 267:3242-3248.
40. Trapnell BC, Chu C-S, Paakko PK, Banks TC, Yoshimura K, Ferrans VJ, Chernick MS, Crystal RG: Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci USA 1991;88:6565-6569.
41. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM: Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 1994; 93:737-749.
42. - currents and expression of CFTR-mRNA. Pediatr Pulmonol 1999;27:251-259.
43. Sood R, Bear C, Auerbach W, Reyes E, Jensen T, Kartner N, Riordan JR, Buchwald M: Regulation of CFTR expression and function during differentiation of intestinal epithelial cells. EMBO J 1992;11:2487-2494.
44. - transport and cystic fibrosis transmembrane conductance regulator mRNA in human intestinal cells. J Biol Chem 1991; 266:4495-4499.
45. Montrose-Rafizadeh C, Blackmon DL, Hamosh A, Oliva MM, Hawkins AL, Curristin SM, Griffin CA, Yang VW, Guggino WB, Cutting GR: Regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gene transcription and alternative RNA splicing in a model of developing intestinal epithelium. J Biol Chem 1992;267:19299-19305.
46. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner E, Widdicombe JH, Gruenert DC: CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;10:38-47.
47. Kopito RR: Biosynthesis and degradation of CFTR. Physiol Rev 1999;79(suppl):167-173.
48. Mohammad-Panah R, Demolombe S, Riochet D, Leblais V, Loussouarn G, Pollard H, Baro I, Escande D: Hyperexpression of recombinant CFTR in heterologous cells alters its physiological properties. Am J Physiol 1998;274:C310-C318.
49. Matthews RP, McKnight GS: Characterization of the cAMP response element of the cystic fibrosis transmembrane conductance regulator gene promoter. J Biol Chem 1996;271:31869-31877.
50. Pittman N, Shue G, Leleiko NS, Walsh MJ: Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation. J Biol Chem 1995;270:28848-28857.
51. Breuer W, Kartner N, Riordan JR, Cabantchik ZI: Induction of expression of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1992;267:10465-10469.
52. 29 cells to cAMP, ATP, neurotensin, ionomycin and hypotonic cell swelling. Pflügers Arch 1994;428:76-83.
53. Breuer W, Glickstein H, Kartner N, Riordan JR, Ausiello DA, Cabantchik IZ: Protein kinase C mediates down-regulation of cystic fibrosis transmembrane conductance regulator levels in epithelial cells. J Biol Chem 1993;268: 13935-13939.
54. Bargon J, Trapnell BC, Yoshimura K, Dalemans W, Pavirani A, Lecocq JP, Crystak RG: Expression of the cystic fibrosis transmembrane conductance regulator gene can be regulated by protein kinase C. J Biol Chem 1992; 267:16056-16060.
55. Kang-Parks S, Dray-Charier N, Munier A, BbrahimiHorn C, Veissiere D, Picard J, Capeau J, Cherqui G, Lascols O: Role for PKC alpha and PKC epsilon in down-regulation of CFTR mRNA in a human epithelial liver cell line. J Hepatol 1998;28:250-262.
56. Bargon J, Trapnell BC, Chu CS, Rosenthal ER, Yoshimura K, Guggino WB, Dalemans W, Pavirani A. Lecocq JP, Crystal RG: Down-regulation of cystic fibrosis transmembrane conductance regulator gene expression by agents that modulate intracellular divalent cations. Mol Cell Biol 1992;12:1872-1878.
57. Breuer W, Slotki IN, Ausiello DA, Cabantchik IZ: Induction of multidrug resistance downregulates the expression of CFTR in colon epithelial cells. Am J Physiol 1993;265:C1711-C1715.
58. 29 colon carcinoma cells. J Cell Physiol 1994;161:393-406.
59. + conductances in airway epithelial cells. Pflügers Arch 1996;431:578-586.
60. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR: Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 1995;83:13-20.
61. Ward CL, Omura S, Kopito RR: Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 1995;83:121-127.
62. Bebok Z, Mazzochi C, King SA, Hong JS, Sorscher EJ: The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary. J Biol Chem 1998;273:29873-29878.
63. Christian WW, Fabunmi RP, Lee MG, Marino CR, Muallem S, Demartino GN, Thomas PJ: Dynamic Association of Proteasomal Machinery with the Centrosome. J Cell Biol 1999;145: 481-490.
64. Johnston JA, Ward CL, Kopito RR: Aggresomes: A cellular response to misfolded proteins. J Cell Biol 1998;143:1883-1898.
65. Marshall J, Fang S, Ostedgaard LS, O'Riordan CR, Ferrara D, Amara JF, Hoppe H, Scheule RK, Welsh MJ, Smith AE: Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro. J Biol Chem 1994;269:2987-2995.
66. Zerhusen B, Zhao J, Xie J, Davis PB, Ma J: A single conductance pore for chloride ions formed by two cystic fibrosis transmembrane conductance regulator molecules. J Biol Chem 1999;274:7627-7630.
67. Ward CL, Kopito RR: Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J Biol Chem 1994;269:25710-25718.
68. - secretion in epithelial cells. Am J Physiol 1993; 265:C688-C694.
69. Jiang X, Hill WG, Pilewski JM, Weisz OA: Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent. Am J Physiol 1997;273: L913-L920.
70. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ: Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992;358:761-764.
71. French PJ, Van Doorninck JH, Peters RH, Verbeeke E, Ameen NA, Marino CR, de Jonge HR, Bijman J, Scholte BJ: A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest 1996;98:1304-1312.
72. Cunningham SA, Worrell RT, Benos DJ, Frizzell RA: cAMP-stimulated ion currents in xenopus oocytes expressing CFTR cRNA. Am J Physiol 1992;262:C783-C788.
73. + channels in Xenopus ooyctes coexpressing CFTR and ENaC. J Physiol (Lond) 1998;508.3:825-836.
74. Cheng SH, Fang SL, Zabner J, Marshall J, Piraino S, Schiavi SC, Jefferson DM, Welsh MJ, Smith AE: Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression. Am J Physiol 1995; 268:L615-L624.
75. Qu BH, Strickland EH, Thomas PJ: Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J Biol Chem 1997:272:15739-15744.
76. Denning GM, Ostedgaard LS, Welsh MJ: Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol 1992;118:551-559.
77. Puchelle E, Gaillard D, Ploton D, Hinnrasky J, Fuchey C, Boutterin MC, Jacquot J, Dreyer D, Pavirani A, Dalemans W: Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am J Respir Cell Mol Biol 1992;7:485-491.
78. Ostergaard LS, Zeiher B, Welsh MJ: Processing of CFTR bearing the P574H mutation differs from wild-type and (&Dgr;)F508-CFTR. J Cell Sci 1999;112:2091-2098.
79. Seibert FS, Linsdell P, Loo TW, Hanrahan JW, Clarke DM, Riordan JR: Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem 1996;271:15139-15145.
80. Seibert FS, Jia Y, Mathews CJ, Hanrahan JW, Riordan JR, Loo TW, Clarke DM: Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry 1997;36:11966-11974.
81. Gregory RJ, Rich DP, Cheng SH, Souza DW. Paul S, Manavalan P, Anderson MP. Wwelsh MJ, Smith AE: Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol 1991;11:3886-3893.
82. Sheppard DN, Travis SM, Ishihara H, Welsh MJ: Contribution of proline residues in the membrane-spanning domains of cystic fibrosis transmembrane conductance regulator to chloride channel function. J Biol Chem 1996;271: 14995-15001.
83. Katzmann DJ, Epping EA, Moye-Rowley WS: Mutational disruption of plasma membrane trafficking of Saccharomyces cerevisiae Yorlp, a homologue of mammalian multidrug resistance protein. Mol Cell Biol 1999;19:2998-3009.
84. Teem JL, Berger HA, Ostedgaard LS, Rich DP, Tsui LC, Welsh MJ: Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast. Cell 1993;73:335-346.
85. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq J-P, Lazdunski M: Altered chloride ion channel kinetics associated with the deltaF508 cystic fibrosis mutation. Nature 1992;354: 526-528.
86. Li C, Ramjeesingh M, Reyes E, Jensen TJ, Chang X-B, Rommens JA, Bear CE: The cystic fibrosis mutation (deltaF508) does not influence the chloride channel activity of CFTR. Nat Genet 1993;3:311-316.
87. Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A, Riordan JR, Grinstein S: The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem 1993;268:21592-21598.
88. Kartner N, Augustinas T, Jensen TJ, Naismith AL, Riordan JR: Mislocalization of deltaF508 CFTR in cystic fibrosis sweat gland. Nat Genet 1992;1:321-327.
89. Xiong X, Chong E, Skach WR: Evidence that endoplasmic reticulum (ER)-associated degradation of cystic fibrosis transmembrane conductance regulator is linked to retrograde translocation from the ER membrane. J Biol Chem 1999;274:2616-2624.
90. - channel is functional when retained in endoplasmic reticulum of mammalian cells. J Biol Chem 1995;270:12347-12350.
91. Sommer T, Wolf DH: Endoplasmic reticulum degradation: Reverse protein flow of no return. FASEB J 1997;11:1227-1233.
92. Pind S, Riordan JR, Williams DB: Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1994;269:12784-12788.
93. 70 and degraded in a pre-Golgi nonlysosomal compartment. Proc Natl Acad Sci USA 1993;90:9480-9484.
94. Meacham GC, Lu Z, King S, Sorscher E, Tousson A, Cyr DM: The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J 1999;18:1492-1505.
95. Loo MA, Jensen TJ, Cui L, Hou Y, Chang XB, Riordan JR: Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J 1998;17:6879-6887.
96. Dupuit F, Kalin N, Brezillon S, Hinnrasky J, Tümmler B, Puchelle E: CFTR and differentiation markers expression in non-CF and delta F-508 homozygous CF nasal epithelium. J Clin Invest 1995;96:1601-1611.
97. Kalin N, Claass A, Sommer M, Puchelle E, Tümmler B: DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis [see comments]. J Clin Invest 1999; 103:1379-1389.
98. Lukacs GL, Segal G, Kartner N, Grinstein S, Zhang F: Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J 1997;328:353-361.
99. Bradbury NA, Cohn JA, Venglarik CJ, Bridges RJ: Biochemical and biophysical identification of cystic fibrosis transmembrane conductance regulator chloride channels as components of endocytic clathrin coated vesicle. J Biol Chem 1994;269:8296-8302.
100. Lukacs GL, Chang XB, Kartner N, Rotstein OD. Riordan JR, Grinstein S: The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH. J Biol Chem 1992; 267:14568-14572.
101. Bradybury NA: Intracellular CFTR: Localization and function. Physiol Rev 1999;79 (suppl):175-191.
102. Biwersi J, Verkman AS: Functional CFTR in endosomal compartment of CFTR-expressing fibroblasts and T84 cells. Am J Physiol 1994;266:C149-C156.
103. Gluck D, Kelly S, al-Awqati Q: The proton translocating ATPase responsible for urinary acidification. J Biol Chem 1982;257:9230-9233.
104. Root KV, Engelhardt JF, Post M, Wilson JW, van Dyke RW: CFTR does not alter acidification of L cell endosomes. Biochem Biophys Res Commun 1994;205:396-401.
105. Seksek O, Biwersi J, Verkman AS: Evidence against defective trans-Golgi acidification in cystic fibrosis. J Biol Chem 1996;271:15542-15548.
106. Imundo L, Barasch J, Prince A, al-Awqati Q: Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface (Published erratum appears in Proc Natl Acad Sci USA 1995;92:11322.) Proc Natl Acad Sci USA 1995;92:3019-3023.
107. Hill WG, Harper GS, Rozaklis T, Boucher RC, Hopwood JJ: Organ-specific over-sulfation of glycosaminoglycans and altered extracellular matrix in a mouse model of cystic fibrosis. Biochem Mol Med 1997;62:113-122.
108. DosanJH A, Lencer W, Brown D, Ausiello DA, Stow JL: Heterologous expression of deltaF508 CFTR results in decreased sialylation of membrane glycoconjugates. Am J Physiol 1994;266:C360-C366.
109. Cheng PW, Boat TF, Cranfill K, Yankaskas JR, Boucher RC: Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest 1989;84:68-72.
110. i regulation in tracheal epithelial cells. Pflügers Arch 1996;432:546-554.
111. Poulsen JH, Fischer H, Illek B, Machen TE: Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci USA 1994;91:5340-5344.
112. Gottlieb RA, Dosanjh A: Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: Possible relevance to cystic fibrosis. Proc Natl Acad Sci USA 1996;93:3587-3591.
113. Wei LY, Hoffman MM, Roepe PD: Altered pHi regulation in 3T3/CFTR clones and their chemotherapeutic drug-selected derivatives. Am J Physiol 1997;272:C1642-C1653.
114. Davies JC, Stern M, Dewar A, Caplen NJ, Munkonge FM, Pitt T, Sorgi F, Huang L, Bush A, Geddes DM, Altin EW: CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am J Respir Cell Mol Biol 1997;16: 657-663.
115. Pier GB, Grout M, Zaidi TS: Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 1997;94:12088-12093.
116. Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, Ratcliff R, Evans MJ, Colledge WH: Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 1998;393:79-82.
117. Bradbury NA, Jilling T, Gabor B, Sorscher EJ, Bridges RJ, Kirk KL: Regulation of plasma membrane recycling by CFTR. Science 1992;256:530-531.
118. - channel. Am J Physiol 1996;271:C1887-C1894.
119. Ameen NA, Martensson B, Bourguinon L, Marino C, Isenberg J, McLaughlin GE: CFTR channel insertion to the apical surface in rat duodenal villus epithelial cells is upregulated by VIP in vivo. J Cell Sci 1999;112: 887-894.
120. Prince LS, Workman RB, Marchase RB: Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 1994;91: 5192-5196.
121. - secretion in T84 cells. J Clin Invest 1991;87:1903-1909.
122. Lehrich RW, Aller SG, Webster P, Marino CR, Forrest JN: Vasoactive intestinal peptide, forskolin, and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. Acute regulation of CFTR trafficking in an intact epithelium. J Clin Invest 1998;101:737-745.
123. McNicholas CM, Nason MW, Jr., Guggino WB, Schwiebert EM, Hebert SC, Giebisch G. Egan ME: A functional CFTR-NBF1 is required for ROMK2-CFTR interaction. Am J Physiol 1997;273:F843-F848.
124. Hug MJ, Thiele IE, Greger R: The role of exocytosis in the activation of the chloride conductance in Chinese hamster ovary cells (CHO) stably expressing CFTR. Pflügers Arch 1997;434:779-784.
125. Howard M, Jilling T, Duvall M, Frizzell RA: cAMP-regulated trafficking of epitope-tagged CFTR. Kidney Int 1996;49:1642-1648.
126. Demolombe S, Baro I, Laurent M, Hongre AS, Pavorani A, Escande D: Abnormal subcellular localization of mutated CFTR protein in a cystic fibrosis epithelial cell line. Eur J Cell Biol 1994;65:214-219.
127. Schwiebert EM, Gruenert DC, Guggino WB. Stanton BA: G protein G alpha i-2 inhibits outwardly rectifying chloride channels in hu7 man airway epithelial cells. Am J Physiol 1995;269:C451-C456.
128. - channels. Am J Physiol 1994;267:C272-C281.
129. Schwiebert EM, Kizer N, Gruenert DC, Stanton BA: GTP-binding proteins inhibit cAMP activation of chloride channels in cystic fibrosis airway epithelial cells. Proc Natl Acad Sci USA 1992;89:10623-10627.
130. - channel in CHO cells stably expressing the cystic fibrosis gene. Nature 1991;352: 628-631.
131. - secretion via CFTR in Calu-3 airway epithelial cells [see comments]. Am J Physiol 1998; 275:C913-C920.
132. Blomfield J, Dascalu J, Lennep EW, Brown JM: Hypersecretion of zymogen granules in the pathogenesis of cystic fibrosis. Gut 1973; 14:558-565.
133. Frates RCJ, Kaizu TT, Last JA: Mucus glycoproteins secreted by respiratory epithelial tissue from cystic fibrosis patients. Pediatr Res 1983;17:30-34.
134. Montserrat C, Merten M, Figarella C: Defective ATP-dependent mucin secretion by cystic fibrosis pancreatic epithelial cells. FEBS Lett 1996;393:264-268.
135. Mergey M, Lemnaouar M, Veissiere D, Perricaudet M, Gruenert DC, Picard J, Capeau J, Brahimi-Horn MC, Paul A: CFTR gene transfer corrects defective glycoconjugate secretion in human CF epithelial tracheal cells. Am J Physiol 1995;269:L855-L864.
136. Pereira MM, Dormer RL, McPherson MA: Mucin secretion mediated by the cystic fibrosis gene protein. CFTR. Biochem Soc Trans 1995;23:5325.
137. Peters RH, French PJ, van Doorninck JH, Lamblin G, Ratcliff R, Evans MJ, Colledge WH, Bijman J, Scholte BJ: CFTR expression and mucin secretion in cultured mouse gall-bladder epithelial cells. Am J Physiol 1996; 271:G1074-G1083.
138. Finkbeiner WE, Shen B-Q, Widdicombe JH: Chloride secretion and function of serous and mucous cells of human airway glands. Am J Physiol 1994;267:L206-L210.
139. Yamaya M, Finkbeiner WE, Widdicombe JH: Altered ion transport by tracheal glands in cystic fibrosis. Am J Physiol 1991;261: L491-L494.
140. Biwersi J, Emans N, Verkman AS: Cystic fibrosis transmembarne conductance regulator activation stimulates endosome fusion in vivo. Proc Natl Acad Sci USA 1996;93: 12484-12489.
141. Santos GF, Reenstra WW: Activation of the cystic fibrosis transmembrane regulator by cyclic AMP is not correlated with inhibition of endocytosis. Biochim Biophys Acta 1994; 1195:96-102.
142. Naren AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, Benos DJ, Quick MW. Kirk KL: Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature 1997;390:302-305.
143. Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, Stutts MJ, Milgram SL: An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 1998;273:19797-19801.
144. Spilmont C, Hinnrasky J, Zahm JM, Jacquot J, Puchelle E, Kuhry JG: CFTR is involved in membrane endocytosis but not in fluid-phase and receptor-mediated endocytosis in human respiratory epithelial cells. Biochem Biophys Res Commun 1996;227:182-188.
145. Shimkets RA, Lifton RP, Canessa CM: The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis. J Biol Chem 1997;272:25537-25541.
146. Hug T, Koslowsky T, Ecke D, Greger R, Kunzelmann K: Actin-dependent activation of ion conductances in bronchial epithelial cells. Pflügers Arch 1995;429:682-690.
147. Prat AG, Xiao Y-F, Ausiello DA. Cantiello HF: cAMP independent regulation of CFTR by the act in cytoskeleton. Am J Physiol 1995; 268:C1552-C1561.
148. - channel in mouse 3T3 fibroblasts. J Physiol (Lond) 1995;489: 745-754.
149. Berdiev BK, Prat AG, Cantiello HF, Ausiello DA, Fuller CM, Jovov B, Benos DJ, Ismailov II: Regulation of epithelial sodium channels by short actin filaments. J Biol Chem 1996; 271:17704-17710.
150. Ismailov II, Berdiev BK, Shlyonsky VG, Fuller CM, Prat AG, Jovov B, Cantiello HF, Ausiello DA, Benos DJ: Role of actin in regulation of epithelial sodium channels by CFTR. Am J Physiol 1997;272:C1077-C1086.
151. Drumm ML, Wilkinson DJ, Smit LS, Worrell RT, Strong TV, Frizzell RA, Dawson DC, Collins FS: Chloride conductance expressed by deltaF508 and other mutant CFTRs in Xenopus oocytes. Science 1991;254:1797-1799.
152. Riordan JR: Therapeutic strategies for treatment of CF based on knowledge of CFTR. Pediatr Pulmonol Suppl 1999;18:83-87.
153. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR: Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996;271:635-638.
154. Brown CR, Hong-Brown LQ, Biwersi J, Verkman AS, Welch WJ: Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1996;1:117-125.
155. Jiang C, Fang SL, Xiao YF, O'Connor SP, Nadler SG, Lee DW, Jefferson DM, Kaplan JM, Smith AE, Cheng SH: Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin. Am J Physiol 1998;275:C171-C178.
156. Roc SM, Prodromou C, O'Brien R, Ladbury JE, Piper PW, Pearl LH: Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem 1999;42:260-266.
157. Loo TW, Clarke DM: Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J Biol Chem 1997;272:709-712.
158. Steagall WK, Drumm ML: Stimulation of cystic fibrosis transmembrane conductance regulator-dependent short-circuit currents across DeltaF508 murine intestines. Gastroenterology 1999;116:1379-1388.